Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
Currently, Ian C. Mortimer occupies the position of Chairman for Appili Therapeutics, Inc. and President, Chief Executive Officer & Director at Xenon Pharmaceuticals, Inc., President, Treasurer & Director at Xenon Pharmaceuticals USA, Inc. (a subsidiary of Xenon Pharmaceuticals, Inc.). Mr. Mortimer is also on the board of Perimeter Medical Imaging, Inc. and Perimeter Medical Imaging AI, Inc.

In the past Ian C. Mortimer occupied the position of Chief Financial Officer & Executive Vice President for Arbutus Biopharma Corp.

He received an undergraduate degree from the University of British Columbia and an MBA from Queen's University.


Current positions of Ian C. Mortimer 
NameTitle Since
Xenon Pharmaceuticals Inc.
(Biotechnology & Medical Research)
Chief Financial & Operating Officer 2015
Perimeter Medical Imaging AI, Inc.
(Advanced Medical Equipment & Technology)
Director 2020
Appili Therapeutics Inc.
(Biotechnology & Medical Research)
Chairman 2020
Perimeter Medical Imaging, Inc. Director 2020
Xenon Pharmaceuticals USA, Inc. President, Treasurer & Director -


Holdings of Ian C. Mortimer 
NameEquities%Valuation
Xenon Pharmaceuticals Inc. (XENE)
(Biotechnology & Medical Research)
20,3000.039%573,881 USD
Perimeter Medical Imaging AI, Inc. (PINK)
(Advanced Medical Equipment & Technology)
113,3330.18%233,466 USD
Appili Therapeutics Inc. (APLI)
(Biotechnology & Medical Research)
00.0000%0 USD


Ian C. Mortimer: Personal Network 
Most Read News 
05/20XAVIER NIEL : UWR shares spike as billionaire Xavier Niel discloses 27% stake
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/24ELON MUSK : In a faceoff with Elon Musk, the SEC blinked
RE
05/19ELON MUSK : Musk says 'Tesla is on my mind 24/7' amid concerns about Twitter distraction
RE
05/17ELON MUSK : Prominent hedge funds invested in Twitter before Musk unveiled plans
RE
05/25ELON MUSK : Twitter investors vote against re-electing Elon Musk ally to board
RE
05/23HOCK TAN : Chipmaker Broadcom in talks to acquire VMware for $60 billion -sources
RE
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
RE
05/12ELON MUSK : Twitter CEO says two leaders to depart, hiring paused amid Musk takeover
RE
More news


© 2022 People and Ownership :   
Ian C. Mortimer : Connections